Earnings per share

12 Months Ended

Jun. 30, 2023

Note 3

. Earnings per share


	2023 A$’000			2022 restated A$’000			2021 restated A$’000

Earnings per share for loss from continuing operations


Loss after income tax attributable to the owners of Kazia Therapeutics Limited		(20,465	)		(25,014	)		(8,420	)

Loss after income tax attributable to the owners of Kazia Therapeutics Limited		(20,465	)		(25,014	)		(8,420	)


	Number			Number			Number

Weighted average number of ordinary shares used in calculating basic earnings per share		184,284,350			132,467,686			117,674,543

Weighted average number of ordinary shares used in calculating diluted earnings per share		184,284,350			132,467,686			117,674,543


	Cents			Cents			Cents

Basic earnings per share		(11.23	)		(18.88	)		(7.16	)
Diluted earnings per share		(11.23	)		(18.88	)		(7.16	)

The number of unissued shares under option that have been excluded from the diluted EPS are

14,780,000

(2023)

8,655,500

(2022) and

4,219,000

(2021).